Accès au site français Welcome to You buy France The french suppliers portal

SHARE THIS COMPANY

twitter linkedin facebook viadeo

You buy France

ATLAB PHARMA

ATLAB Pharma aims at developing radioimmunotherapy as a breakthrough in cancer treatment.

Radioimmunotherapy is a tumor-specific delivery system using monoclonal antibodies conjugated to radioisotopes (radio-antibodies) to target radiation to cancer cells wherever they have disseminated in the body, thus expanding the well-proven efficacy of radiotherapy from localized tumors to metastatic cancers.

ATLAB Pharma is at the forefront of developing safe and efficient radio-antibodies based on new generation therapeutic radioisotopes Lutetium-177 and Astatine-211.

ATLAB Pharma lead drug candidate, ATL101, has been shown to have a favorable safety profile and anti-tumor activity in Phase I and Phase II clinical trials in patients with castrate-resistant prostate cancer.

+ Read more

 

Company profile

Related activities :

Health, pharmacy, life sciences

Export area :

European Union

Local presence :

European Union

Target countries :

European Union

North America

North Asia

More information

...About

   

 

 

 

 

 

 

 

Business France contributes to the development and success of French and foreign businesses wishing to expand abroad by supporting them throughout the lifetime of their projects, and is driven by an efficient, result-oriented working culture. > Read more

 

Discover the French know how:
   

      

  

Rail industry